Program News
News and stories about the UNC Lineberger Pancreatic Cancer Center of Excellence
-
Pancreatic Cancer Action Network names Yeh to scientific and medical advisory board
Jen Yeh, MD, has been appointed to the Pancreatic Cancer Action Network’s scientific and medical advisory board, which is comprised of leading scientists, clinicians and healthcare professionals across the United States.
-
NCI awards Earp, Pylayeva-Gupta five-year, $2.69 million pancreatic cancer research grant
The NCI has awarded has awarded Shelley Earp, MD, and Yuliya Pylayeva-Gupta, PhD, a research project grant to investigate approaches to overcome barriers to pancreatic cancer immunotherapies.
-
Pylayeva-Gupta awarded Hettleman Prize
UNC named UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, one of four recipients of the Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement.
-
UNC Lineberger pancreatic cancer therapy studies backed by 5-year, $10.9 million NIH SPORE grant
The National Cancer Institute has awarded the UNC Lineberger Pancreatic Cancer Center of Excellence a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant.
-
UNC Lineberger pancreatic cancer researchers receive five-year, $4.6 million grants from National Cancer Institute
The NCI awarded $9.3 million in support of two five-year research projects from researchers in the UNC Lineberger Pancreatic Cancer Center of Excellence in partnership with other institutions.
-
Yeh, Maduekwe selected as inaugural recipients of the Lustgarten Foundation’s LEAD Project grant
The Lustgarten Foundation has awarded its inaugural Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grant to Jen Jen Yeh, MD, in support of her PROmoting CLinicAl TrIal EngageMent for Pancreatic Cancer App Study (PROCLAIM Study).
-
Pylayeva-Gupta published in Cell Reports Medicine
UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, was the corresponding author of a paper published in Cell Reports Medicine that examined how B cells might be reprogrammed to improve anti-tumor immune response in pancreatic cancer. The study was led by a former research associate, Rahul Mirlekar.
-
PanCAN backs Der and Bryant Labs with two-year, $340,000 award
UNC Lineberger’s Channing Der, PhD, and Kirsten Bryant, PhD, are among seven recipients of the inaugural Pancreatic Cancer Action Network (PanCAN) Therapeutic Accelerator Collaborative Award, which provides a total of $340,000 in grant support over two years.